* Allscripts Healthcare Solutions Inc MDRX.OQ MDRX.O is
expected to show a rise in quarterly revenue when it reports
results on May 5.
* The Chicago Illinois-based company is expected to report
a
1.1% increase in revenue to $372.418 million from $368.4 million
a year ago, according to the mean estimate from 4 analysts,
based on Refinitiv data.
* Refinitiv's mean analyst estimate for Allscripts
Healthcare
Solutions Inc is for earnings of 21 cents per share. For the
same quarter last year, the company reported earnings of 19
cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 4
"hold" and 1 "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Allscripts
Healthcare Solutions Inc is $23.75, above its last closing
price of $20.58.
* Previous quarterly performance (using preferred earnings
measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Dec. 31 2021 0.35 0.32 0.79 Beat 145.2
Sep. 30 2021 0.18 0.18 0.27 Beat 47.3
Jun. 30 2021 0.18 0.17 0.23 Beat 31.9
Mar. 31 2021 0.15 0.15 0.19 Beat 23.5
Dec. 0.22 0.21 0.29 Beat 36.6
31 2020
Sep. 30 2020 0.19 0.19 0.20 Beat 5.6
Jun. 30 2020 0.12 0.12 0.18 Beat 49.3
Mar. 31 2020 0.14 0.15 0.09 Missed -39.4
This summary was machine generated May 4 at 02:02 GMT. All
figures in US dollars unless otherwise stated